Combining Radiation and Immune Checkpoint Blockade in the Treatment of Head and Neck Squamous Cell Carcinoma.
PD-L1
PD1
abscopal effect
immune checkpoint inhibitors
immunotherapy
radiation therapy
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2019
2019
Historique:
received:
19
12
2018
accepted:
12
02
2019
entrez:
22
3
2019
pubmed:
22
3
2019
medline:
22
3
2019
Statut:
epublish
Résumé
Head and neck squamous cell carcinoma (HNSCC) is a significant cause of morbidity and mortality worldwide. Current treatment options, even though potentially curative, have many limitations including a high rate of complications. Over the past few years immune checkpoint inhibitors (ICI) targeting cytotoxic lymphocyte antigen-4 (CTLA-4), programmed cell death protein 1 (PD-1), and programmed cell death ligand 1 (PD-L1) have changed treatment paradigms in many malignancies and are currently under investigation in HNSCC as well. Despite improvements in treatment outcomes and the implementation of combined modality approaches long-term survival rates in patients with locally advanced HNSCC remain suboptimal. Accumulating evidence suggests that under certain conditions, radiation may be delivered in conjunction with ICI to augment efficacy. In this review, we will discuss the immune modulating mechanisms of ICI and radiation, how changing the dose, fractionation, and field of radiation may alter the tumor microenvironment (TME), and how these two treatment modalities may work in concert to generate durable treatment responses against HNSCC.
Identifiants
pubmed: 30895168
doi: 10.3389/fonc.2019.00122
pmc: PMC6414812
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
122Références
Oral Maxillofac Surg Clin North Am. 2014 May;26(2):123-41
pubmed: 24794262
Front Oncol. 2014 Nov 28;4:325
pubmed: 25506582
Nat Rev Clin Oncol. 2018 Aug;15(8):477-494
pubmed: 29872177
Nat Immunol. 2016 Sep 20;17(10):1142-9
pubmed: 27648547
J Neurosurg. 1994 Jun;80(6):1074-7
pubmed: 8189262
Science. 2011 Mar 25;331(6024):1565-70
pubmed: 21436444
Eur J Cancer. 2019 Jan;107:142-152
pubmed: 30576970
N Engl J Med. 2016 Nov 10;375(19):1856-1867
pubmed: 27718784
Nature. 2007 Dec 6;450(7171):903-7
pubmed: 18026089
Front Immunol. 2012 Mar 21;3:51
pubmed: 22566933
N Engl J Med. 2017 Nov 16;377(20):1919-1929
pubmed: 28885881
Prog Exp Tumor Res. 1970;13:1-27
pubmed: 4921480
Oral Oncol. 2014 Jul;50(7):627-32
pubmed: 24819861
Cancer Growth Metastasis. 2018 Mar 09;11:1179064418761639
pubmed: 29551910
Eur J Cancer. 2016 Nov;68:156-162
pubmed: 27764686
Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):624-629
pubmed: 29678530
Nat Immunol. 2002 Nov;3(11):991-8
pubmed: 12407406
Oncogene. 2011 Mar 10;30(10):1147-58
pubmed: 21151176
Nat Rev Immunol. 2003 Dec;3(12):984-93
pubmed: 14647480
N Engl J Med. 2010 Aug 19;363(8):711-23
pubmed: 20525992
Br J Dermatol. 2018 Aug;179(2):296-300
pubmed: 29766492
Oncologist. 2008;13 Suppl 4:2-9
pubmed: 19001145
Front Oncol. 2018 Aug 29;8:310
pubmed: 30211111
Nat Rev Clin Oncol. 2017 Jun;14(6):365-379
pubmed: 28094262
J Immunol. 2008 Mar 1;180(5):3132-9
pubmed: 18292536
Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):737-42
pubmed: 9336157
Front Oncol. 2012 Oct 26;2:153
pubmed: 23112958
Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):296-303
pubmed: 30191864
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
Vaccine. 2002 Dec 19;20 Suppl 4:A40-5
pubmed: 12477427
Immunity. 2014 Nov 20;41(5):843-52
pubmed: 25517616
Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):728-34
pubmed: 15701862
J Exp Med. 2018 May 7;215(5):1287-1299
pubmed: 29622565
Nat Rev Clin Oncol. 2017 Jul;14(7):399-416
pubmed: 28117416
Int J Radiat Biol. 2018 May;94(5):488-494
pubmed: 29108460
J Clin Oncol. 2021 Jan 1;39(1):30-37
pubmed: 32822275
Oncoimmunology. 2014 Apr 25;3:e28518
pubmed: 25071979
Cell Rep. 2016 Apr 12;15(2):274-87
pubmed: 27050509
Int J Radiat Biol. 1999 Nov;75(11):1421-7
pubmed: 10597915
Cancer. 2015 Apr 1;121(7):1128-37
pubmed: 25538019
Nat Rev Immunol. 2017 Feb;17(2):97-111
pubmed: 27748397
Cancer Res. 2011 Apr 1;71(7):2488-96
pubmed: 21300764
Nat Commun. 2017 Jun 09;8:15618
pubmed: 28598415
Annu Rev Immunol. 2002;20:323-70
pubmed: 11861606
Nat Rev Cancer. 2012 Dec;12(12):860-75
pubmed: 23151605
Front Pharmacol. 2017 Aug 23;8:561
pubmed: 28878676
Immunity. 2004 Aug;21(2):137-48
pubmed: 15308095
Clin Cancer Res. 2009 Sep 1;15(17):5379-88
pubmed: 19706802
N Engl J Med. 2018 Dec 13;379(24):2342-2350
pubmed: 30280658
Curr Opin Immunol. 2006 Apr;18(2):206-13
pubmed: 16464564
Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):427-34
pubmed: 14751512
JAMA. 2010 Mar 17;303(11):1070-6
pubmed: 20233825
Mol Ther. 2010 May;18(5):912-20
pubmed: 20197756
Cancer Res. 2004 Nov 1;64(21):7985-94
pubmed: 15520206
N Engl J Med. 2012 Mar 8;366(10):925-31
pubmed: 22397654
Cancer Res. 2010 Apr 1;70(7):2697-706
pubmed: 20215523
Cancer Immunol Immunother. 2011 Aug;60(8):1161-71
pubmed: 21626032
N Engl J Med. 2004 May 6;350(19):1937-44
pubmed: 15128893
Clin Cancer Res. 2018 Oct 15;24(20):5058-5071
pubmed: 29898992
Semin Radiat Oncol. 2015 Jan;25(1):18-27
pubmed: 25481262
Radiat Res. 2010 Feb;173(2):148-57
pubmed: 20095846
Science. 2015 Apr 3;348(6230):69-74
pubmed: 25838375
Oncologist. 2015 Jul;20(7):812-22
pubmed: 26069281
N Engl J Med. 2011 Jun 30;364(26):2517-26
pubmed: 21639810
Blood. 2009 Jul 16;114(3):589-95
pubmed: 19349616
Immunity. 2013 Jul 25;39(1):1-10
pubmed: 23890059
J Immunol. 2000 Jan 1;164(1):144-51
pubmed: 10605005
Cancer Res. 2014 Oct 1;74(19):5458-68
pubmed: 25274032
Nat Rev Cancer. 2015 Jul;15(7):409-25
pubmed: 26105538
Front Oncol. 2018 Mar 28;8:86
pubmed: 29644214
Annu Rev Immunol. 2004;22:329-60
pubmed: 15032581
Eur J Cancer. 2016 Jan;52:1-9
pubmed: 26623522
Cancer Immunol Res. 2015 Apr;3(4):345-55
pubmed: 25527358
Curr Probl Cancer. 2016 Jan-Feb;40(1):25-37
pubmed: 26582738
Gynecol Oncol. 1996 Mar;60(3):468-74
pubmed: 8774659
J Natl Cancer Inst. 1979 Nov;63(5):1229-35
pubmed: 291749
JAMA Oncol. 2018 Aug 1;4(8):1123-1124
pubmed: 29327059
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1128-35
pubmed: 21093169
J Immunol. 2008 Sep 1;181(5):3099-107
pubmed: 18713980
Nat Immunol. 2013 Oct;14(10):1014-22
pubmed: 24048123
Immunity. 2013 Feb 21;38(2):209-23
pubmed: 23438821
Head Neck. 2017 Mar;39(3):595-601
pubmed: 27997054
N Engl J Med. 2004 May 6;350(19):1945-52
pubmed: 15128894
J Exp Med. 2006 May 15;203(5):1259-71
pubmed: 16636135
Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1306-10
pubmed: 22208977
J Immunol. 2005 Jun 15;174(12):7516-23
pubmed: 15944250